Atopic Dermatitis as a Multifactorial Skin Disorder. Can the Analysis of Pathophysiological Targets Represent the Winning Therapeutic Strategy?

MLA

Magnifico, Irene, et al. “Atopic Dermatitis as a Multifactorial Skin Disorder. Can the Analysis of Pathophysiological Targets Represent the Winning Therapeutic Strategy?” Pharmaceuticals (14248247), vol. 13, no. 11, Nov. 2020, p. 411. EBSCOhost, https://doi.org/10.3390/ph13110411.

APA

Magnifico, I., Petronio Petronio, G., Venditti, N., Cutuli, M. A., Pietrangelo, L., Vergalito, F., Mangano, K., Zella, D., & Di Marco, R. (2020). Atopic Dermatitis as a Multifactorial Skin Disorder. Can the Analysis of Pathophysiological Targets Represent the Winning Therapeutic Strategy? Pharmaceuticals (14248247), 13(11), 411. https://doi.org/10.3390/ph13110411

Chicago

Magnifico, Irene, Giulio Petronio Petronio, Noemi Venditti, Marco Alfio Cutuli, Laura Pietrangelo, Franca Vergalito, Katia Mangano, Davide Zella, and Roberto Di Marco. 2020. “Atopic Dermatitis as a Multifactorial Skin Disorder. Can the Analysis of Pathophysiological Targets Represent the Winning Therapeutic Strategy?” Pharmaceuticals (14248247) 13 (11): 411. doi:10.3390/ph13110411.